• Explore /
  • Poster
  • / Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.

Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.

Abstract Poster

Authors

Sofia Merajver

Sofia Diana Merajver

University of Michigan Rogel Cancer Center, Ann Arbor, MI

Sofia Diana Merajver , Aaron M Udager , Angel Qin , Kiran Lagisetty , Liwei Bao , Xu Cheng , Hamadi Madhi , Laura Goo , Varun Kathawate , Peter Ulintz , Albert Liu , Habib Serhan , Vishal Navani , John L. Jefferies , Muhammad Sajawal Ali , Michael Monument , Johannes Ruediger Kratz , Amber Smith , Matthew Soellner , Nathan Merrill

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics

Sub Track

Other Technology and Innovations

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 215)

DOI

10.1200/JCO.2024.42.23_suppl.215

Abstract #

215

Poster Bd #

K10

Abstract Disclosures

Similar Posters

First Author: Laura Mezquita

First Author: Tianhong Li

First Author: T. Li

First Author: Kaushal Parikh